Shingles in Alberta: Before and after publicly funded varicella vaccination

Vaccine

Volumn 32, Issue 47, 2014, Pages 6319-6324

  Russell, Margaret L ^a   Dover, Douglas C ^b   Simmonds, Kimberley A ^b   Svenson, Lawrence W ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Alberta (Ministry of) Learning   (Canada)

Author keywords

Alberta epidemiology; Herpes zoster epidemiology; Herpes zoster prevention and control; Population surveillance

Indexed keywords

CHICKENPOX VACCINE;

ADULT; AGED; ARTICLE; CANADA; CHILD; COMORBIDITY; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; VACCINATION; ADOLESCENT; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MIDDLE AGED; POISSON DISTRIBUTION; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALBERTA; CHICKENPOX VACCINE; CHILD; FEMALE; HERPES ZOSTER; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; POISSON DISTRIBUTION; PUBLIC HEALTH; VACCINATION; YOUNG ADULT;

EID: 84908051381     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.018     Document Type: Article

References (22)

1. Brisson M., Edmunds W.J., Gay N.J. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 2003, 70(Suppl. 1):S31-S37.
2. Brisson M., Edmunds W.J., Gay N.J., Law B., De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 2000, 125(03):651-669.
3. Brisson M., Gay N.J., Edmunds W.J., Andrews N.J. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002, 20(19-20):2500-2507.
4. Gidding H.F., Brisson M., Macintyre C.R., Burgess M.A. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health 2005, 29(6):544-551.
5. Brisson M., Melkonyan G., Drolet M., De S.G., Thibeault R., De W.P. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine 2010, 28(19):3385-3397.
6. Russell M.L., Schopflocher D.P., Svenson L.W., Yiannakoulias N., Grimsrud K., Virani S.N. The changing epidemiology of chickenpox in Alberta. Vaccine 2005, 23(46-47):5398-5403.
7. Government of Alberta Expanded immunization program means better protection against chickenpox: second dose available August 1 for children aged four to six years old. Government of Alberta 2013, 7-24-2012, 5-13-2013.
8. Kwong J.C., Tanuseputro P., Zagorski B., Moineddin R., Chan K.J. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program?. Vaccine 2008, 26(47):6006-6012.
9. Russell M.L., Schopflocher D.P., Svenson L., Virani S.N. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 2007, 135(6):908-913.
10. Brisson M., Edmunds W.J., Law B., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001, 127(02):305-314.
11. Surveillance & Assessment Branch AH Interactive Health Data Application: Population Estimates 2012, 3-13-2013.
12. Alberta Health and Wellness Comparison of Alberta population counts between the AHCIP Registry and the 2006 census. Edmonton, AB: Government of Alberta 2009, Jan 2.
13. Cleveland W.S., Devlin S.J. Locally weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc 1988, 83(403):596-610.
14. Statistics Canada.Immigration and ethnocultural diversity in Canada: National Household Survey 2011 Statistics Canada 2013, Report No.: Catalogue no. 99-010-X2011001.
15. Tanuseputro P., Zagorski B., Chan K.J., Kwong J.C. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine 2011, 29(47):8580-8584.
16. Yawn B.P., Wollan P., St.Sauver J. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?. Am J Epidemiol 2011, 174(9):1054-1061.
17. Mullooly J.P., Riedlinger K., Chun C., Weinmann S., Houston H. Incidence of Herpes Zoster, 1997-2002. Epidemiol Infect 2005, 133(2):245-253.
18. Reynolds M.A., Chaves S.S., Harpaz R., Lopez A.S., Seward J.F. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008, 197(Suppl. 7).
19. Last J.M. A Dictionary of Public Health 2007, Oxford University Press.
20. Rimland D., Moanna A. Increasing incidence of Herpes Zoster among veterans. Clin Infect Dis 2010, 50(7):1000-1005.
21. Jackson L.A., Reynolds M.A., Harpaz R. Hospitalizations to treat Herpes Zoster in older adults: causes and validated rates. Clin Infect Dis 2008, 47(6):754-759.
22. National Advisory Committee on Immunization Statement on the Recommended Use of Herpes Zoster Vaccine. Canada Communicable Disease Report 2010, 36(ACS1):1-19.